Kim Steengaard

Title: Innovator Spotlight: Kim Steengaard of Hvidovre, Denmark

Introduction: Kim Steengaard is a prolific inventor based in Hvidovre, Denmark, known for his significant contributions to medical technology. With a total of six patents to his name, Kim's innovations primarily focus on improving insulin delivery systems, enhancing the efficiency and safety of medication administration for patients.

Latest Patents: Kim Steengaard's latest patents include groundbreaking designs aimed at elevating the standard of medical delivery systems. His first notable patent, a **Cartridge and Medical Delivery System Accommodating Such Cartridge**, introduces a cartridge with a mechanical coding system. This system utilizes a circular protrusion at the distal end of the cartridge, which is specifically designed to indicate the concentration of insulin contained within. By ensuring that only cartridges with the correct concentration fit into the delivery system, this innovation enhances patient safety and simplifies drug administration.

Another of his recent patents is an **Injection Needle Assembly**. This assembly includes an injection needle and a needle hub that can be mounted on a syringe for easy securing. The design features an injection part that extends axially from the hub, tapering to an obliquely cut end, which is optimized for subcutaneous injections. The needle’s dimensions, allowing for a specific outer and bore diameter, contribute to a more comfortable and efficient injection experience for users.

Career Highlights: Kim Steengaard has been an integral part of Novo Nordisk A/S, a global leader in diabetes care and hormone replacement therapies. His role at the company has allowed him to advance his research and development efforts, focusing on innovative solutions in the medical field. Throughout his career, he has demonstrated a steadfast commitment to improving the lives of individuals requiring insulin therapy.

Collaborations: Throughout his career, Kim has collaborated with other notable professionals in the industry, including colleagues Svend Elk and Steffen Lav. Together, they have shared insights and expertise, enhancing the development of innovative medical devices aimed at patient care.

Conclusion: Kim Steengaard’s contributions to medical technology, particularly in insulin delivery systems, showcase his inventive spirit and dedication to healthcare improvement. As he continues to innovate within Novo Nordisk A/S, his work not only reflects personal achievement but also leads to significant advancements in patient care and safety.